Taichung/Taipei Veterans General Hospital / Taiwan
Reason: Awarded in recognition of his outstanding scientific contributions to our understanding of the pathophysiology of Asian diabetes and its complications. He also promoted application of Artificial Intelligence to improve diabetes care with smart technology. He has continuously contributed to AASD activities and nurtured many young health care professionals and researchers who are now becoming leaders in the field of diabetes.
Previous awards: "2019 Award for Diabetes in Society and Culture (The International Diabetes Federation)", "2017 Outstanding Contribution Award (The International Diabetes Federation)", and many other awards

Institute for Molecular and Cellular Regulation, Gunma University / Japan
Reason: Awarded in recognition of his outstanding scientific achievements in advancing our understanding of the signaling pathways regulating proliferation and function of pancreatic beta cells. His research has clarified the molecular mechanisms underlying the compensatory beta-cell response to insulin resistance and islet dysfunction.
Previous awards: "2021 Lilly Research Award (The Japan Diabetes Society)", "2019 Research Award (The Japan Endocrine Society)", "2012 Young Investigator Award (The Japan Diabetes Society)", and many other awards

Department of Medicine & Therapeutics, Faculty of Medicine, The Chinese University of Hong Kong / Hong Kong
Reason: Awarded in recognition of her outstanding scientific achievements in clarifying the phenotypic heterogeneity, rising incidence, comorbidities, and premature death of Chinese people with young onset diabetes by using the Hong Kong Diabetes Register, and for taking a leadership role in the Hong Kong Diabetes Surveillance Database study (HKDSD).
Previous awards: "2019 Harry Keen Memorial Award (The International Diabetes Epidemiology Group)", "2011 Young Investigator Award (The International Diabetes Epidemiology Group)", and many other awards